Current Management of Specialty Drugs, Specialty Pharmacies and Biosimilar Drugs

The value of specialty oncology drugs.

OBJECTIVE To estimate patients' elasticity of demand, willingness to pay, and consumer surplus for five high-cost specialty medications treating metastatic disease or hematologic malignancies. DATA SOURCE/STUDY SETTING Claims data from 71 private health plans from 1997 to 2005. STUDY DESIGN This is a revealed preference analysis of the demand for specialty drugs among cancer patients. We ex...

Specialty courts: current issues and future prospects

The reasons individual offenders engage in criminal activity are numerous and varied. Three key priority areas have emerged in recent years – reducing crime related to drug dependency and mental health, reducing the over-representation of Indigenous offenders and reducing the incidence of domestic violence. Policy-makers and criminal justice practitioners have recently responded with the develo...

Effective Performance of Knowledge Management in Single-Specialty Cardiovascular Hospital

Introduction: Organizations can manage knowledge inside and create organizational learning mechanisms to integrate Knowledge Management (KM) at their core of strategic policies. Objective: This research was conducted to identify and prioritize influential factors on the effective performance of KM in a specialized cardiovascular on-call hospital. Materials and Methods: The methodology of this...

Chiral Drugs: Current Status of the Industry and the Market

Health plan utilization and costs of specialty drugs within 4 chronic conditions.

BACKGROUND Drugs are most typically defined as specialty because they are expensive; however, other criteria used to define a drug as specialty include biologic drugs, the need to inject or infuse the drug, the requirement for special handling, or drug availability only via a limited distribution network. Specialty drugs play an increasingly important role in the treatment of chronic conditions...